Seeing Is Believing

Currently out of the existing stock ratings of Erin Wright, 128 are a HOLD (31.92%), 232 are a BUY (57.86%), 41 are a SELL (10.22%).
Analyst Erin Wright, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 73.89% that have a potential upside of 17.36% achieved within 194 days.
Erin Wright’s has documented 1,015 price targets and ratings displayed on 3 stocks. The coverage is on Technology, Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CAH, Cardinal Health at 12-Aug-2026.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS ) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 12-Feb-2026
$12
$-1 (-7.69%)
$6.5
Hold Since 22-Jan-2025
$10
$-3 (-23.08%)
$20
Hold Since 01-Apr-2025
$12
$-1 (-7.69%)
$12
Hold Since 26-Apr-2024
$10.15
$-2.85 (-21.92%)
$7
Which stock is Erin Wright is most bullish on?
Which stock is Erin Wright is most reserved on?
What Year was the first public recommendation made by Erin Wright?